Poor Results in a Phase 3 Trial Deal a Blow to a Promising, Controversial ALS Drug.
Saved in:
| Title: | Poor Results in a Phase 3 Trial Deal a Blow to a Promising, Controversial ALS Drug. |
|---|---|
| Authors: | BURLING, STACEY |
| Source: | Neurology Today. 4/18/2024, Vol. 24 Issue 8, p1-17. 3p. |
| Database: | Academic Search Ultimate |
| ISSN: | 15337006 |
|---|---|
| DOI: | 10.1097/01.nt.0001012792.20466.07 |
